PharmaMar, one of Luye Pharma’s collaborative partners, has announced that the U S Food and Drug Admini...
December 1, 2019, Luye Pharma Group has announced the acquisition of Shandong Boan Biological Technology Co L...
As one of the nation’s largest private mental health providers, October 10 is a very important date for ...
The first FDA De Novo designated NGS assay for detecting HIV-1 drug resistance mutations (DRMs)
We are fully prepared for the global launch of LY03004 and other innovative formulations
From China, for the world
TOP